CAS: 179068-02-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PHCCC REF: IN-DA00ABSYCAS: 179068-02-1 | 99% | To inquire | Tue 07 Jan 25 | |
PHCCC REF: TM-T3464CAS: 179068-02-1 | 99.31% | 46.00 €~519.00 € | Tue 14 Jan 25 | |
PHCCC REF: 3D-EHA06802CAS: 179068-02-1 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00ABSY
2mg | 116.00 € | ||
5mg | 127.00 € | ||
10mg | 160.00 € | ||
25mg | 476.00 € | ||
50mg | 596.00 € | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
PHCCC
CAS:179068-02-1
PHCCC is a Group I mGluR antagonist and enhances mGluR4 function; also blocks mGluR2/8.
Formula:
C17H14N2O3
Purity:
99.31%
Color and Shape:
Solid
Molecular weight:
294.3
Ref: TM-T3464
2mg | 46.00 € | ||
5mg | 59.00 € | ||
10mg | 90.00 € | ||
25mg | 183.00 € | ||
50mg | 347.00 € | ||
100mg | 519.00 € | ||
1mL*10mM (DMSO) | 69.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
PHCCC
CAS:179068-02-1
PHCCC is a prodrug that is hydrolyzed in vivo to two molecules of the active …
Formula:
C17H14N2O3
Purity:
Min. 95%
Molecular weight:
294.3 g/mol
Ref: 3D-EHA06802
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
250µg | Discontinued | Request information | |
500µg | Discontinued | Request information |